Clinical Trials Directory

Trials / Completed

CompletedNCT02619955

Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity

Hepcicor Cohort : Clinical, Biological, Genetic and Fonctional charactérization of Rare Iron Overlaod phénotypes Associated With Hepcidin Deficiency Excluding C282Y Homozygosity

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study explores the hepcidin deficiency causes of rare iron overload (excluding C282Y homozygosity), and aim to characterize this iron overload in term of clinical, biological, genetic and functional spacificities.

Detailed description

Chronic iron overload are responsible for morbidity and mortality. There are many causes, genetic and acquired. Hepcidin deficiency related to genetic desease is one of them. This study concerns specifically this cause, and seeks to characterize these iron overloads on clinical, biological, genetic and functional point of view. A significant number of patients with chronic iron overload, present a phenotype of hepcidin deficiency. This profile is characterized by an elevated plasma iron increased serum transferrin saturation, a transferrin saturation, and a parenchyma distribution of iron overload. These diseases either remains unexplained or are associated with mutations in the gene involved in iron metablism regulation. The main objective of this study is to characterize these iron overloads with phenotype of hepcidin deficiency not related to homozygosity C282Y (clinical, biological and genetic).

Conditions

Interventions

TypeNameDescription
OTHERsamples with DNA

Timeline

Start date
2016-03-01
Primary completion
2023-01-01
Completion
2023-01-01
First posted
2015-12-02
Last updated
2023-01-18

Locations

9 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02619955. Inclusion in this directory is not an endorsement.